US Stock MarketDetailed Quotes
XCUR Exicure
- 0.5351
- +0.2311+76.02%
Close Jul 19 16:00 ET
- 0.3913
- -0.1438-26.87%
Post 19:59 ET
4.63MMarket Cap-354P/E (TTM)
0.5806High0.2950Low14.02MVolume0.3039Open0.3040Pre Close7.53MTurnover294.81%Turnover RatioLossP/E (Static)8.65MShares1.140052wk High2.10P/B2.55MFloat Cap0.291452wk Low--Dividend TTM4.76MShs Float115.2000Historical High--Div YieldTTM93.95%Amplitude0.2914Historical Low0.5360Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Jiyoung Hwang
- Director and Chief Financial Officer
- 16.97K
- Joshua Miller
- Chief Accounting Officer
- --
- Hojoon Lee
- Director
- 7.22K
- Dongho Lee
- Independent Director
- 7.22K
- Hyuk Joon Ko
- Independent Director
- 7.22K
- Minhee Eom
- Independent Director
- 5.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
